The Oncology Institute of Hope and Innovation

Long Beach, California 90805

1 studies enrolling now · 8 studies all time

What they study most

Cancer, Cancer of Pancreas, Carcinoma, Non-Small-Cell Lung, Cervical Carcinoma, Colon Cancer, Colorectal Cancer, Endometrial Carcinoma, Fallopian Tube Carcinoma, Follicular Lymphoma, HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Lung Cancer, Non Small Cell Lung Cancer

Studies at this site

• A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer — Recruiting now
• Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study) — Stopped early
• A Study of PF-06873600 in People With Cancer — Stopped early
• A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation — Running, not enrolling
• A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) — Stopped early
• Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) — Status unconfirmed
• Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) — Stopped early
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed